Login to Your Account



Other news to note


Monday, December 9, 2013
Genmab A/S, of Copenhagen, said it reached a new milestone in its Duobody technology collaboration with Janssen Biotech Inc., a unit of New Brunswick, N.J.-based Johnson & Johnson, triggering a $4 million milestone.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription